Cutaneous necrosis as a terminal paraneoplastic thromboembolic event in a patient with non-Hodgkin's lymphoma

Journal of Internal Medicine

Volumn 245, Issue 3, 1999, Pages 301-305

  Luboshitz, J ^a   Bairey, O ^a   Blickstein, D ^b   Vaknin, H ^a   Okon, E ^a   Lahav, J ^a   Prokocimer, M ^a  

^a RABIN MEDICAL CENTER   (Israel)

^b NONE

Author keywords

Disseminated intravascular coagulation; Lymphoma; Non Hodgkin's; Thromboembolism

Indexed keywords

COMPLEMENT MEMBRANE ATTACK COMPLEX; IMMUNOGLOBULIN M; INTERLEUKIN 1ALPHA; THROMBOPLASTIN;

ADULT; ARTICLE; BLOOD VESSEL WALL; CASE REPORT; COMPLEMENT ACTIVATION; HUMAN; HUMAN TISSUE; IMMUNE COMPLEX DEPOSITION; IMMUNOFLUORESCENCE; MALE; NONHODGKIN LYMPHOMA; PARANEOPLASTIC SYNDROME; PRIORITY JOURNAL; SKIN BLOOD VESSEL DISORDER; SKIN NECROSIS; THROMBOEMBOLISM;

HUMANS; LYMPHOMA, NON-HODGKIN; MALE; MIDDLE AGED; NECROSIS; PARANEOPLASTIC SYNDROMES; SKIN; SKIN DISEASES; THROMBOEMBOLISM;

EID: 0033064077     PISSN: 09546820     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2796.1999.00475.x     Document Type: Article

References (13)

1. 1 Goad KE, Gralnick HR. Coagulation disorder in cancer. Hematol Oncol Clin of North Am 1996; 10: 457-84.
2. 2 Green KB, Silverstein RL. Hypercoagulability in cancer. Hematol Oncol Clin of North Am 1996; 10: 499-530.
3. 3 Ottinger H, Belka C, Kozole G, Engelhard M, Meusers P, Paar D. et al. Deep venous thrombosis and pulmonary embolism in high-grade non-Hodgkin's lymphoma: incidence, cause and prognostic relevance. Eur J Haematol 1995; 54: 186-94.
4. 4 Ott P, Astrup L, Jensen RH, Nyeland B, Pedersen B. Assessment of D-dimer in plasma: diagnostic value in suspected deep venous thrombosis of the leg. Acta Med Scand 1988; 224: 263-67.
5. 5 Aiach M, Gandrille S, Emmerich J. A review of mutations causing deficiencies of antithrombin, protein C and protein S. Thromb Haemost 1995; 74: 81-89.
6. 6 Edwards RL, Silver J, Rickles FR. Human tumor procoagulants: registry of the Subcommittee on Haemostasis and Malignancy of the Scientific and Standardization Committee, International Society of Thrombosis and Haemostasis. Thromb Haemost 1993; 69: 205-13.
7. 7 Kessinger A, Armitage JO. Prothrombotic hemostatic abnormalities in patient with refractory malignant lymphoma presenting for autologous stem cell transplantation. Bone Marrow Transplant 1991; 7: 475-79.
8. 8 Colman MG, Haire WD, Lieberman RP, Lund G, Kessinger A, Armitage JO. Catheter-related thrombosis in patients with refractory lymphoma undergoing autologous stem cell transplantation. Bone Marrow Transplant 1991; 7: 235-40.
9. 9 Saadi S, Holzknecht RA, Patte CP, Stern DM, Platt JL. Complement-mediated regulation of tissue factor activity in endothelium. J Exp Med 1995; 182: 1807-14.
10. 10 Platt JL, Vercellotti GM, Lindman BJ, Oegema TR Jr, Bach FH, Dalmasso AP. Release of heparan sulfate from endothelial cells. J Exp Med 1990; 171: 1363-68.
11. 11 Saadi S, Platt JL. Transient perturbation of endothelial integrity induced by natural antibodies and complement. J Exp Med 1995; 181: 21-31.
12. 12 Leventhal JR, Matas AJ, Sun LH, Reif S, Bolman RM, Dalmasso AP, Platt JL. The immunopathology of cardiac xenograft rejection in the guinea pig to rat model. Transplantation (Baltimore) 1993; 56: 1-8.
13. 13 Parker W, Bruno D, Holzknecht ZE, Platt JL. Characterization and affinity isolation of xenoreactive human natural antibodies. J Immunol 1994; 153: 3791-803.